	Israel Securities Authority			Tel Aviv Stock Exchange		C001 ( Public )		Reported via MAGNA:	17/09/2025
	www.isa.gov.il			www.tase.co.il				Reference:	2025-02-070389	Time of broadcast: 23:40 23:40

Report of Periodic or Interim Report

Regulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

FORM 10-K - דוח שנתי לשנה שהסתיימה ביום 30.06.25

ea025613001-10k_pluriinc_AsFiled_bannerless_isa.pdf

Link to filing on foreign stock exchange (optional): _________


References of previous documents relating to this matter(the reference does not constitute incorporation by reference):



Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 06/08/2024
Address: Matam Park 5 , Haifa 31905 ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: Info@Pluristem.Com Company site: www.pluristem.com

Previous names of reporting entity: PLURISTEM THERAPEUTICS INC

Name of the Signatory: Zalts Zelig Liat Position of Signatory in the reporting corporation: CFO, Senior Vice president & Treasurer Name of Employer Company:
Address: Matam Park 5 , Haifa 3190500 Telephone: 074-7108600 Facsimile: E-mail: liat.zalts@pluri-biotech.com 1